# Normobaric Hyperoxia Combined With Endovascular Treatment in Acute Ischemic Stroke (OPENS-2)

Study · id `cardio:ct-nct04681651` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04681651](<https://clinicaltrials.gov/study/NCT04681651>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04681651

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 282 participants.

## Technical summary

Registry record NCT04681651. Randomized; triple masking; primary purpose treatment. Start 2021-04-22 (actual); primary completion 2023-05-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 282 participants (enrolled count; ClinicalTrials.gov record NCT04681651, source copy `cardio:ctgov-nct04681651-2023-07-06`, retrieved 2026-10-26)
- Started: 2021-04-22 (actual) (ClinicalTrials.gov record NCT04681651, source copy `cardio:ctgov-nct04681651-2023-07-06`, retrieved 2026-10-26)
- Primary completion: 2023-05-05 (actual) (ClinicalTrials.gov record NCT04681651, source copy `cardio:ctgov-nct04681651-2023-07-06`, retrieved 2026-10-26)
- Completion: 2023-05-05 (actual) (ClinicalTrials.gov record NCT04681651, source copy `cardio:ctgov-nct04681651-2023-07-06`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04681651, source copy `cardio:ctgov-nct04681651-2023-07-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04681651-2023-07-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Normobaric Hyperoxia Combined With Endovascular Treatment in Acute Ischemic Stroke (OPENS-2)
- Condition: Stroke, Acute
- Condition: Neuroprotection
- Intervention (Drug): Normobaric Hyperoxia
- Intervention (Drug): Sham Normobaric Hyperoxia
- Intervention (Procedure): Endovascular Thrombectomy
- Lead sponsor: Capital Medical University
- Lead sponsor class: OTHER
- Collaborator: Tianjin Huanhu Hospital
- Collaborator class: OTHER
- Collaborator: Shengli Oilfield Hospital
- Collaborator class: OTHER
- Collaborator: Beijing Fengtai You'anmen Hospital
- Collaborator class: UNKNOWN
- Collaborator: Jiujiang University Affiliated Hospital
- Collaborator class: OTHER\_GOV
- Collaborator: Zhangzhou Municipal Hospital of Fujian Province
- Collaborator class: OTHER
- Collaborator: Baotou Central Hospital
- Collaborator class: OTHER
- Collaborator: Luoyang Central Hospital
- Collaborator class: OTHER
- Collaborator: Nanyang Central Hospital
- Collaborator class: OTHER
- Collaborator: Qingdao Central Hospital
- Collaborator class: OTHER
- Collaborator: The Third People's Hospital of Jinan
- Collaborator class: UNKNOWN
- Collaborator: Rizhao People's Hospital
- Collaborator class: OTHER
- Collaborator: Anyang People's Hospital
- Collaborator class: UNKNOWN
- Collaborator: Shanghai 10th People's Hospital
- Collaborator class: OTHER
- Collaborator: Dalian Municipal Central Hospital
- Collaborator class: OTHER
- Collaborator: Zhoukou Central Hospital
- Collaborator class: OTHER
- Collaborator: Nanyang Nanshi Hospital
- Collaborator class: OTHER
- Collaborator: Nanning Second People's Hospital
- Collaborator class: OTHER
- Collaborator: Zhumadian Central Hospital
- Collaborator class: OTHER
- Collaborator: Taizhou Hospital
- Collaborator class: OTHER
- Collaborator: Second Affiliated Hospital of Nanchang University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Normobaric hyperoxia combined with endovascular treatment for acute ischaemic stroke in China (OPENS-2 trial): a multicentre, randomised, single-blind, sham-controlled trial (`cardio:pubmed-39922675`)

Courtesy of the U.S. National Library of Medicine.

## Registry records

Records a program assembled from a public registry; no person wrote or checked them. They are counted here, not listed: the JSON record of this page lists each one in its relationships.

- 11 registry organizations

## Provenance

Content hash: f7e1819ef3cc9c467bc0ea572c0e2cffbdcc21ca826c17c19123d0a79b8fc181
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
